No products in the cart.
Methadone 5mg β The Complete Medical Guide
Introduction to Methadone 5mg
Methadone 5mg is aΒ long-acting synthetic opioidΒ classified as aΒ Schedule II controlled substance. As the lowest commercially available tablet strength, it serves as aΒ starting dose for both pain management and medication-assisted treatment (MAT) for opioid use disorder. Unlike shorter-acting opioids, methadone providesΒ sustained relief with unique pharmacokineticsΒ that require special clinical consideration.
Methadone 5mg
Methadone 5mg is a prescription medication used to treat severe pain and manage opioid dependence. As a long-acting opioid, Methadone works by altering the way the brain and nervous system respond to pain, providing relief for chronic pain conditions or as part of a comprehensive treatment plan for opioid addiction.
Medical Uses & Indications
FDA-Approved Uses
β
Β Opioid use disorder maintenanceΒ (MAT programs)
β
Β Chronic pain managementΒ (When alternatives inadequate)
β
Β Detoxification treatmentΒ (Opioid withdrawal management)
Key Clinical Features
β’Β Duration:Β 24-36 hours (vs 4-6h for morphine)
β’Β Half-life:Β 15-60 hours (highly variable)
β’Β DEA Classification:Β Schedule II (Special prescribing requirements)
β’Β QTc Prolongation Risk:Β Dose-dependent
Pharmacology & Effects
Unique Mechanisms
β’ NMDA receptor antagonism (reduces tolerance)
β’ Serotonin/norepinephrine reuptake inhibition
β’ ΞΌ-opioid receptor agonist
Therapeutic Effects
β Sustained analgesia (delayed onset: 30min-4h)
β Suppression of withdrawal symptoms
β Reduced opioid craving
Risk Profile
β’Β Accumulation risk:Β Due to long half-life
β’Β Overdose danger:Β Peak respiratory depression at 3-5 days
β’Β Street names:Β Fizzies, Amidone
Dosing Protocols
For Pain Management
β’Β Opioid-naive:Β Start 2.5-5mg every 8-12 hours
β’Β Titration:Β Increase by β€5mg every 5-7 days
β’Β Max daily:Β Typically 30-40mg (pain)
For MAT (Opioid Treatment Programs)
β’Β Induction:Β 20-30mg initial dose
β’Β Maintenance:Β 60-120mg/day (average)
β’Β Supervised administration required
Critical Safety Notes
β Β QTc monitoring essentialΒ (ECG at >40mg/day)
β Β Never use PRN for painΒ (Accumulation risk)
β Β Avoid CYP3A4/2B6 inhibitors
β Β Special certification required for MAT prescribing
Safety Profile
Common Side Effects
β’ Constipation (less than other opioids)
β’ Excessive sweating
β’ Sleep disturbances
β’ Peripheral edema
Black Box Warnings
βΒ Life-threatening QT prolongation
βΒ Respiratory depression risk
βΒ Accidental ingestion/overdose
βΒ Drug interactions danger
Overdose Management
Unique Considerations
β’ Delayed onset (may occur days after dose increase)
β’ Prolonged resuscitation often needed
Treatment Protocol
Naloxone administrationΒ (higher doses often required)
Continuous monitoringΒ (24-48 hours minimum)
ECG for QTc assessment
Respiratory support
Harm Reduction Strategies
Locked storageΒ (Diversion risk)
Take-home dose regulationsΒ (MAT programs)
Patient education about accumulation risk
Regular ECG monitoring
Clinical Alternatives
For Pain Management
β’Β Morphine ER
β’Β Oxycodone CR
β’Β BuprenorphineΒ (Lower risk)
For MAT
β’Β Buprenorphine/naloxone
β’Β Naltrexone XR
β’Β Behavioral therapies
Special Populations
| Population | Considerations |
|---|---|
| Elderly | Start β€2.5mg, slow titration |
| Hepatic Impairment | 50% dose reduction |
| Cardiac History | Strict QTc monitoring |
| Pregnancy | Preferred MAT option |
| Quantity | 30, 60, 90 |
|---|
Be the first to review “Methadone 5mg”
Related products
PILLS π
Price range: $177.00 through $533.00
This product has multiple variants. The options may be chosen on the product page 
Reviews
There are no reviews yet.